aromasil has been researched along with d-alpha tocopherol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Mishra, B; Padaliya, R; Patel, RR | 1 |
| Alam Rizvi, MM; Amin, S; Mir, SR; Perwez, A; Rizwanullah, M | 1 |
1 review(s) available for aromasil and d-alpha tocopherol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for aromasil and d-alpha tocopherol
| Article | Year |
|---|---|
Exemestane encapsulated vitamin E-TPGS-polymeric nanoparticles: preparation, optimization, characterization, and in vitro cytotoxicity assessment.
Topics: Androstadienes; Antineoplastic Agents, Phytogenic; Biological Transport; Cell Survival; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Liberation; Factor Analysis, Statistical; Female; Humans; Hydrogen-Ion Concentration; Kinetics; MCF-7 Cells; Nanoparticles; Particle Size; Polyesters; Vitamin E | 2017 |
Exemestane encapsulated polymer-lipid hybrid nanoparticles for improved efficacy against breast cancer: optimization,
Topics: Androstadienes; Antineoplastic Agents; Biomimetic Materials; Cell Survival; Drug Carriers; Drug Compounding; Drug Liberation; Drug Stability; Factor Analysis, Statistical; Fluorescent Dyes; Gastric Juice; Humans; Kinetics; Liposomes; MCF-7 Cells; Nanoparticles; Phosphatidylcholines; Polyesters; Rhodamines; Vitamin E | 2021 |